首页> 外国专利> Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester, process for preparing the composition and its use for the treatment of obesity

Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester, process for preparing the composition and its use for the treatment of obesity

机译：包含脂肪酶抑制剂和蔗糖脂肪酸单酯的药物组合物，制备该组合物的方法及其在肥胖症治疗中的用途

页面导航

摘要
著录项
相似文献

摘要

Pharmaceutical composition comprising a lipase inhibitor having a melting point equal or higher than 37 °C, preferably orlistat, a sucrose fatty acid mono-ester and optionally one or more pharmaceutically acceptable excipients. Process for preparing the composition by mixing components thereof. Use of the composition and components thereof for the manufacture of medicaments for the treatment and prevention of obesity.

机译：药物组合物，其包含具有等于或高于37℃的熔点的脂肪酶抑制剂，优选奥利司他，蔗糖脂肪酸单酯和任选地一种或多种药学上可接受的赋形剂。通过混合其组分制备组合物的方法。所述组合物及其组分在制备用于治疗和预防肥胖症的药物中的用途。

著录项

公开/公告号SK287602B6

专利类型
公开/公告日2011-03-04

原文格式PDF
申请/专利权人 F.HOFFMANN-LA ROCHE AG;
展开▼

申请/专利号SK20030001609
发明设计人 MAEDER KARSTEN;MARTIN RAINER EUGEN;RAAB SUSANNE;SCHEIBLER LUKAS CHRISTOPH;SCHINDLER THOMAS;SCHROEDER MARCO;
展开▼

申请日2002-05-29
分类号A61K31/365;A61K47/02;A61K9;A61K9/20;A61K31/337;A61K31/7024;A61K45;A61K47/10;A61K47/24;A61K47/26;A61K47/32;A61K47/34;A61K47/38;A61P3/04;A61P43;
国家 SK
入库时间 2022-08-21 18:04:44

相似文献

专利
外文文献
中文文献